5/16
07:17 am
glue
Monte Rosa Therapeutics Announces Pricing of $100 Million Underwritten Public Offering [Yahoo! Finance]
Medium
Report
Monte Rosa Therapeutics Announces Pricing of $100 Million Underwritten Public Offering [Yahoo! Finance]
5/16
07:00 am
glue
Monte Rosa Therapeutics Announces Pricing of $100 Million Underwritten Public Offering
Medium
Report
Monte Rosa Therapeutics Announces Pricing of $100 Million Underwritten Public Offering
5/15
04:09 pm
glue
Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]
Medium
Report
Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]
5/15
04:01 pm
glue
Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Medium
Report
Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
5/9
07:06 am
glue
Monte Rosa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
Monte Rosa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
5/9
07:00 am
glue
Monte Rosa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
Medium
Report
Monte Rosa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
5/2
04:13 pm
glue
Monte Rosa Therapeutics Announces the Departure of Owen Wallace, Ph.D., Chief Scientific Officer [Yahoo! Finance]
Low
Report
Monte Rosa Therapeutics Announces the Departure of Owen Wallace, Ph.D., Chief Scientific Officer [Yahoo! Finance]
5/2
04:01 pm
glue
Monte Rosa Therapeutics Announces the Departure of Owen Wallace, Ph.D., Chief Scientific Officer
Low
Report
Monte Rosa Therapeutics Announces the Departure of Owen Wallace, Ph.D., Chief Scientific Officer
5/9/2024
07:00 am
GLUE
monte rosa therapeutics, inc.
BEAT
Report
3.6%
monte rosa therapeutics, inc.
11/9/2023
07:00 am
GLUE
monte rosa therapeutics, inc.
BEAT
Report
-10.3%
monte rosa therapeutics, inc.
8/10/2023
07:15 am
GLUE
monte rosa therapeutics, inc.
BEAT
Report
-1.6%
monte rosa therapeutics, inc.
5/16
04:07 pm
glue
Form 8-K Monte Rosa Therapeutics, For: May 15
Medium
Report
Form 8-K Monte Rosa Therapeutics, For: May 15
5/16
04:04 pm
glue
Form 424B5 Monte Rosa Therapeutics,
Medium
Report
Form 424B5 Monte Rosa Therapeutics,
5/15
04:06 pm
glue
Form 424B5 Monte Rosa Therapeutics,
Medium
Report
Form 424B5 Monte Rosa Therapeutics,
5/13
08:41 pm
glue
Form SC 13D/A Monte Rosa Therapeutics, Filed by: New Enterprise Associates 17, L.P.
Low
Report
Form SC 13D/A Monte Rosa Therapeutics, Filed by: New Enterprise Associates 17, L.P.
5/9
07:46 am
glue
Form 10-Q Monte Rosa Therapeutics, For: Mar 31
Medium
Report
Form 10-Q Monte Rosa Therapeutics, For: Mar 31
5/9
07:06 am
glue
Form 8-K Monte Rosa Therapeutics, For: May 09
Medium
Report
Form 8-K Monte Rosa Therapeutics, For: May 09
5/2
04:03 pm
glue
Form 8-K Monte Rosa Therapeutics, For: Apr 29
Low
Report
Form 8-K Monte Rosa Therapeutics, For: Apr 29
5/1
04:26 pm
glue
Form 144 Monte Rosa Therapeutics, Filed by: Jones Jullian G
Medium
Report
Form 144 Monte Rosa Therapeutics, Filed by: Jones Jullian G
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register